Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CD44 attenuates metastatic invasion during breast cancer progression.
Lopez JI, Camenisch TD, Stevens MV, Sands BJ, McDonald J, Schroeder JA. Lopez JI, et al. Among authors: Schroeder JA. Cancer Res. 2005 Aug 1;65(15):6755-63. doi: 10.1158/0008-5472.CAN-05-0863. Cancer Res. 2005. PMID: 16061657
MUC1 is a novel regulator of ErbB1 receptor trafficking.
Pochampalli MR, el Bejjani RM, Schroeder JA. Pochampalli MR, et al. Among authors: Schroeder JA. Oncogene. 2007 Mar 15;26(12):1693-701. doi: 10.1038/sj.onc.1209976. Epub 2006 Sep 18. Oncogene. 2007. PMID: 16983337
Intracellular MUC1 peptides inhibit cancer progression.
Bitler BG, Menzl I, Huerta CL, Sands B, Knowlton W, Chang A, Schroeder JA. Bitler BG, et al. Among authors: Schroeder JA. Clin Cancer Res. 2009 Jan 1;15(1):100-9. doi: 10.1158/1078-0432.CCR-08-1745. Clin Cancer Res. 2009. PMID: 19118037 Free PMC article.
MUC1 drives c-Met-dependent migration and scattering.
Horm TM, Bitler BG, Broka DM, Louderbough JM, Schroeder JA. Horm TM, et al. Among authors: Schroeder JA. Mol Cancer Res. 2012 Dec;10(12):1544-54. doi: 10.1158/1541-7786.MCR-12-0296. Epub 2012 Nov 27. Mol Cancer Res. 2012. PMID: 23193156 Free PMC article.
106 results
Jump to page
Feedback